ArticleBMC pulmonary medicine2025
TFNAs induce autophagy via activation of the nonclassical cGAS-STING signalling pathway to attenuate acute lung injury in mice.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Tetrahedral Framework Nucleic Acids (tFNAs) for Lung Injury Repair: Mechanisms, Therapeutic Applications, and Future Directions.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAcute lung injury is a common and fatal inflammatory condition in critically ill patients. Tetrahedral framework nucleic acids (TFNAs) have good potential for treating inflammatory diseases. The aim of this study was to use TFNAs in the treatment of acute lung injury (ALI) in mice to investigate the effect and possible mechanism.
methodThe characteristics of the TFNAs, including particle size and cellular uptake, were detected. TFNAs were subsequently used to treat an ALI mouse lung epithelial cells (MLE12) model with or without an autophagy inhibitor. Flow cytometry and Western blotting (WB) were performed to detect apoptosis and autophagy. The oxidative stress level was assessed by measuring the malondialdehyde (MDA) content, superoxide dismutase (SOD) activity and reactive oxygen species (ROS) content. A survival curve of the ALI model mice treated with TFNAs was constructed, and the lung injury score was assessed through pathological staining. The lung wet/dry weight ratio and inflammatory cytokine content in bronchoalveolar lavage fluid were measured and recorded. Transcription sequencing was performed to elucidate the biological processes associated with TFNA treatment. Finally, the regulatory effect of the cGAS-STING signalling pathway on TFNA-induced autophagy was explored.
resultThe synthesized TFNAs are typical nanomaterials. TFNAs significantly reduced the apoptosis rate according to flow cytometry and decreased the BAX/BCL2 ratio in MLE12 cells. Meanwhile, the autophagy level increased, as indicated by the increased expression of the ATG5, ATG7 and LC3II proteins when the cells were incubated with TFNAs. TFNAs could also inhibit the accumulation of ROS, increasing SOD activity and reducing the MDA content. Autophagy inhibitors can significantly inhibit the autophagy and antiapoptotic effects of TFNAs. In the ALI mouse model, TFNAs effectively reduced mortality, BALF inflammatory factor levels, pulmonary oedema, lung injury scores and neutrophil infiltration. The protective effect was significantly reduced with the use of autophagy inhibitors. In addition to autophagy, antigen processing and presentation, antiviral biological processes, and cytoplasmic membrane signal receptor complex functions were significantly upregulated, indicating that TFNAs might activate the cGAS-STING signalling pathway. Inhibition of the cGAS-STING signalling pathway effectively suppressed TFNA-induced autophagy.
conclusionThis study is the first to demonstrate that TFNAs protect MLE-12 cells against LPS-induced oxidative stress injury via autophagy activated by the nonclassical cGAS-STING signalling pathway. Therefore, TFNAs can attenuate ALI and improve patient prognosis in mice. These findings indicate that the cGAS-STING signalling pathway may be a basic mechanism contributing to various therapeutic immunologic effects. This study demonstrated the value of TFNAs in the treatment of ALI, with potential clinical translational value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.